These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 29457212)
21. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge? Al-Batran SE; Lorenzen S Hematol Oncol Clin North Am; 2017 Jun; 31(3):441-452. PubMed ID: 28501086 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic approaches to gastroesophageal junction adenocarcinomas. Blom RL; Bogush T; Brücher BL; Chang AC; Davydov M; Dudko E; Leong T; Polotsky B; Swanson PE; van Rossum PS; Ruurda JP; Sagaert X; Tjulandin S; Schraepen MC; Sosef MN; van Hillegersberg R Ann N Y Acad Sci; 2014 Sep; 1325():197-210. PubMed ID: 25266026 [TBL] [Abstract][Full Text] [Related]
23. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction]. Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538 [TBL] [Abstract][Full Text] [Related]
24. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery]. Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535 [TBL] [Abstract][Full Text] [Related]
25. Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management? Lin D; Khan U; Goetze TO; Reizine N; Goodman KA; Shah MA; Catenacci DV; Al-Batran SE; Posey JA Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e88-e95. PubMed ID: 31099690 [TBL] [Abstract][Full Text] [Related]
26. Combination chemoradiation therapy: the whole is more than the sum of the parts. Mamon HJ; Tepper JE J Clin Oncol; 2014 Feb; 32(5):367-9. PubMed ID: 24419110 [No Abstract] [Full Text] [Related]
27. Reply to E. C. Smyth et al. Hulshof MC; Oppedijk V; van der Gaast A J Clin Oncol; 2014 Sep; 32(27):3081-2. PubMed ID: 25071131 [No Abstract] [Full Text] [Related]
28. Reply to E. C. Smyth et al. Mamon HJ; Tepper JE J Clin Oncol; 2014 Sep; 32(27):3082. PubMed ID: 25071102 [No Abstract] [Full Text] [Related]
29. [A case of adenocarcinoma of the esophagogastric junction successfully treated with chemoradiation therapy]. Ebisui C; Okada K; Nishigaki T; Owada Y; Nagase H; Mukai R; Momozane T; Murakami M; Ide Y; Yanagisawa T; Murata K; Yokouchi H; Tamai M; Kinuta M Gan To Kagaku Ryoho; 2011 Nov; 38(12):2143-5. PubMed ID: 22202310 [TBL] [Abstract][Full Text] [Related]
30. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry. Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366 [TBL] [Abstract][Full Text] [Related]
31. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction]. Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346 [TBL] [Abstract][Full Text] [Related]
33. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach? Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755 [TBL] [Abstract][Full Text] [Related]
34. Individualized surgical strategies for cancer of the esophagogastric junction. Stein HJ; Feith M; Siewert JR Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787 [TBL] [Abstract][Full Text] [Related]
35. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Briasoulis E; Fatouros M; Roukos DH Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806 [No Abstract] [Full Text] [Related]
36. Histopathologic classification of adenocarcinoma of the esophagogastric junction. Baldus SE Recent Results Cancer Res; 2010; 182():29-38. PubMed ID: 20676869 [No Abstract] [Full Text] [Related]
37. ASO Author Reflections: Neoadjuvant Chemotherapy Combined with Immunotherapy is a Promising Strategy for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma. Sun X; Lyu J; Yin Y; Tao K Ann Surg Oncol; 2024 Nov; 31(12):8179-8180. PubMed ID: 39212861 [No Abstract] [Full Text] [Related]
38. [Treatment procedures for adenocarcinoma of the esophagogastric junction]. Moesta KT; Hünerbein M; Schlag PM Chirurg; 2003 Apr; 74(4):381-92; quiz 392-3. PubMed ID: 12719881 [No Abstract] [Full Text] [Related]
39. Controversies in the treatment of local and locally advanced gastric and esophageal cancers. Cohen DJ; Leichman L J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302 [TBL] [Abstract][Full Text] [Related]